-+ 0.00%
-+ 0.00%
-+ 0.00%

TAYSHA GENE THERAPIES AND CATALENT EXPAND STRATEGIC PARTNERSHIP TO INCLUDE FUTURE COMMERCIAL MANUFACTURING SUPPORT OF TSHA-102 GENE THERAPY FOR RETT SYNDROME

Reuters·08/03/2026 12:00:03

Please log in to view news